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The present study was carried out to determine the possible mechanism of 
antinociception and site of activity of the crude aqueous extract of Haruan (Channa 
striatus) (ASH) in mice using the abdominal constriction test. The ASH, obtained after 
chloroform:methanol (CM) (2:l; vlv) extraction (24 hrs) of the fresh Haruan fillet, was 
evaporated to remove the methanol residue and used throughout the study. The first study 
was carried out to ascertain the dry weight and antinociceptive profile of ASH. The 
second study was carried out to determine the amino acids and fatty acids compositions, 
as well as the polypeptide profile of ASH. The third study was carried out to determine 
the actual onset and offset of ASH activity after its subcutaneous (SC) or intraperitoneal 
(IP) administration at four different sets of time (0, 5, 30 and 60 min). The fourth and 
fifth studies were carried out to determine the involvement of opioid and non-opioid 
receptors, respectively, in the ASH antinociceptive activity. All of the antagonists of 
opioidergic, muscarinic, nicotinic, a- and P-adrenergic, dopaminergic, serotonergic and 
y-aminobutyric acid (GABA) receptors were administered (SC) 10 min prior to ASH 
(SC) administration. The sixth study was carried out to determine the role of L- 
argininelnitric oxide/cyclic 3'5'-guanosine monophosphate (L-arginine/NO/cGMP) 
pathway in the ASH antinociceptive activity. The precursor (L-arginine) and inhibitor 
@IG-nitro-L-arginine methyl esters (L-NAME)) for NO, as well as the inhibitor for cGMP 
(methylene blue (MB), were administered (SC) 5 min before ASH administration (SC). 
In all of the above-mentioned studies that involved the use of antinociceptive test, the 
0.6% acetic acid-induced abdominal constriction test in mice was used as an assay to 
evaluate the ASH antinociceptive activity. All data obtained were analysed using the 
One-way Analysis of Variance (ANOVA) followed by the Tukey test with P<0.05 as the 
limit of significance. 
From the data obtained, the ASH, which exhibited significant (P<0.05) and 
concentration/dosage-dependent antinociceptive activity, yielded 1.89g/10.0ml of white 
coloured powder after subjection to the freeze-drying process. The ASH was also found 
to contain all the important amino acids with major amino acids found are glycine 
(35.77% -+ 0.58), alanine (10.19% + 1.27), lysine (9.44 + 0.56), aspartic acid (8.53 -+ 
1.15) and proline (6.86% -+ 0.78). Furthermore, the ASH was also found to contain high 
composition of palmitic acid (C16:O) (35.93% * 0.63), oleic acid (C18: 1) (22.96% A 
0.40), stearic acid (C18:O) (15.31% * 0.33), linoleic acid (C18:2) (1 1.45% * 0.3 1) and 
arachidonic acid (C20:4) (7.44% rt 0.83). The ASH was also found to produce at least 
four major fractions (at the retention times of 8.919, 9.841, 10.263 and 10.744), when 
subjected to the high performance liquid chromatography (HPLC) process, that are 
believed to be polypeptides. The onset time and the offset time of the ASH 
antinociceptive activity, which are concentration-dependent and concentration- 
independent, occurred between 0 to 5 min, and 60 min after its SC administration. 
Interestingly, changing the route of administration from SC to IP caused significant 
(Pc0.05) increase in the ASH antinociceptive activity with the concentration-independent 
onset time of activity observed immediately after the ASH administration with no 
apparent offset time. The activity was found to reach the maximum effect 30 min after 
the ASH administration regardless of the route of administration used. Pretreatment with 
naloxone at all dosages did not cause any significant changes in the ASH antinociceptive 
activity indicating that the activity did not involve an opioid receptor mechanism, and 
thus confirmed the report made by Dambisya et al. (1999). Re-treatment with various 
types of non-opioid receptor antagonists demonstrated the involvement of at least four 
=of receptors (muscarinic, GABA*, a-adrenergie d s e r o t o ~ g k )  in the 
mechanism of ASH antinociceptive activity. Pre-treatment with atropine and bicuculine 
almost completely blocked (P<0.05), while pre-treatment with phenoxybenzamine and 
methysergide significantly (Pc0.05) reduced half of the ASH activity. The role of L- 
arginine/NO/cGMP pathway in ASH antinociceptive activity was also observed after 
pretreatment of the ASH with L-arginine, L-NAME or MB, but not with D-arginine. 
Pretreatment with L-arginine was found to significantly (PC0.05) reduce the ASH 
antinociceptive activity, whereas pretreatment with L-NAME or MB were found to 
enhance (Pc0.05) the activity. Based on the finding, low concentration of NO, limited by 
the presence of higher concentration of ASH, and inhibition of cGMP system play 
important role in ASH antinociceptive activity. However, the actual mechanism 
underlying this phenomenon is yet to be fully understood. 
As a conclusion, we suggest that the ASH-produced antinociceptive activity could be due 
to the presence of various types of amino acids and fatty acids, as well as four major 
fractions, and involved activation of at least four types of the non-opioid receptors 
(namely the muscarinic, GABA*, a-adrenergic and serotonergic) and the L- 
arginine/NO/cGMP pathway. 
Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia 
sebagai memenuhi keperluan ijazah Doktor Falsafah 
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Kajian terkini ini dijalankan untuk menentukan mekanisme dan tapak tindakan 
antinosiseptif yang mungkin terlibat bagi ekstrak akues kasar Haruan (Channa striatus) 
(ASH) dengan menggunakan ujian pencerutan abdominal keatas mencit. ASH, diperolehi 
selepas pengekstrakan (24 jam) filet segar Haruan menggunakan k1oroforrn:metanol 
(CM) (2:l; vlv), dievaporasikan untuk menyingkirkan residu metanol dan digunakan 
sepanjang kajian dijalankan. Kajian pertama dijalankan bagi menentukan berat kering 
dan profil antinosiseptif bagi ASH. Kajian kedua dijalankan untuk menentukan 
komposisi asid-asid amino dan asid-asid lemak, serta profil polipeptida bagi ASH. Kajian 
ketiga dijalankan untuk menentukan masa sebenar bermula dan berakhirnya aktiviti 
antinosiseptif ASH selepas pemberian secara subkutaneus (SC) atau intraperitonial (IP) 
pada empat set masa yang berbeza (0, 5, 30 dan 60 min). Kajian keempat dan kelima 
dijalankan untuk menentukan penglibatan reseptor-reseptor opioid dan bukan-opioid, 
masing-masing, dalam aktiviti antinosiseptif ASH. Kesemua antagonis-antagonis bagi 
reseptor-reseptor opioidergik, muskarinik, nikotinik, a- dan P-adrenergik, dopaminergik, 
serotonergik dan asid y-aminobutirik (GABA), diberikan (SC) 10 min sebelum 
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pemberian ASH (SC). Kajian keenam dijalankan untuk menentukan peranan laluan L- 
arginindnitrik oksidd 3'5'-  guanosina monofosfat siklik (L-arginine/NO/cGMP) dalam 
aktiviti antinosiseptif ASH. Prekursor (L-arginina) dan perencat (NG-nitro-L-arginina 
metil ester (L-NAME)) bagi NO, serta perencat (metilena biru (MB)) bagi cGMP, 
diberikan (SC) 5 min sebelum pemberian ASH (SC). Dalam kesemua kajian yang 
dinyatakan di atas yang melibatkan penggunaan ujian antinosiseptif, ujian pencerutan 
abdominal keatas mencit yang dicetus oleh 0.6% asid asetik telah digunakan sebagai 
assai untuk menilai aktiviti antinosiseptif ASH. Kesemua data yang telah diperolehi 
dianalisa menggunakan One-way Analysis of Variance ('NOVA) diikuti oleh ujian Tukey 
dengan P<0.05 sebagai had bererti. 
Dari data yang telah diperolehi, ASH, yang menunjukkan aktiviti antinosiseptif yang 
bererti (P<0.05) dan bergantung kepada kepekatanldos, telah menghasilkan 1.89g/10.0ml 
serbuk berwarna putih selepas menjalani proses beku-kering. ASH juga didapati 
mengandungi kesemua asid-asid amino penting dengan asid-asid amino utama yang 
didapati adalah glisina (35.77% * 0.58), alanina (10.19% i 1.27), lisina (9.44 * 0.56), 
asid aspartik (8.53 * 1.15) dan prolina (6.86% * 0.78). Tambahan pula, ASH juga 
didapati mengandungi komposisi tinggi asid palmitik (C16:O) (35.93% * 0.63), asid oleik 
(C18:l) (22.96% i 0.40), asid stearik (C18:O) (15.31% 0.33), asid linoleik (C18:2) 
(1 1.45% i 0.31) dan asid arakidonik (C20:4) (7.44 i 0.83). ASH juga didapati 
menghasilkan empat fraksi utama (pada masa penahanan iaitu 8.919, 9.841, 10.263 dan 
10.744) apabila didedahkan kepada kromatografi cecair berprestasi tinggi (HPLC), yang 
dipercayai adalah polipeptida-polipeptida. Masa bermula dan berakhirnya aktiviti 
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antinosiseptif ASH, yang bergantung dan tidak bergantung kepada kepekatan, masing- 
masing terhasil diantara 0 dan 5 min, dan 60 min selepas pemberiannya secara SC. Yang 
menariknya, penukaran kaedah pemberian dari SC kepada IP menyebabkan peningkatan 
yang bererti (P<0.05) dalam aktiviti antinosiseptif ASH dengan masa bermulanya aktiviti, 
yang tidak bergantung kepada kepekatan, dilihat serta-merta selepas pemberian ASH 
tanpa masa be ra l i r  yang nyata. Aktiviti tersebut juga didapati mencapai kesan 
maksimum 30 min selepas pemberian ASH tanpa mengambilkira kaedah pemberian yang 
digunakan. Pra-rawatan dengan nalokson pada semua dos tidak menyebabkan sebarang 
perubahan bererti dalam aktiviti antinosiseptif ASH menunjukkan bahawa aktiviti 
tersebut tidak melibatkan mekanisme reseptor opioid dan, dengan itu mengesahkan 
laporan yang dibuat oleh Dambisya et al. (1999). Pra-rawatan dengan pelbagai jenis 
antagonis-antagonis reseptor menunjukkan penglibatan sekurang-kurangnya empat jenis 
reseptor (muskarinik, GABA*, a-adrenergik and serotonergik) dalam mekanisme aktiviti 
antinosiseptif ASH. Pra-rawatan dengan atropina dan bikukulina menghalang hampir 
keseluruhan (P<0.05), manakala pra-rawatan dengan fenoksibenzamina dan 
methysergide menurunkan secara bererti (P<0.05) separuh dari aktiviti ASH. Peranan 
laluan L-arginine/NO/cGMP dalam aktiviti antinosiseptif ASH juga dapat dilihat selepas 
pra-rawatan keatas ASH dengan L-arginina, L-NAME atau MB, tetapi tidak D-arginina. 
Pra-rawatan dengan L-arginine telah didapati menurunkan aktiviti antinosispetif ASH 
secara bererti (P<0.05), manakala pra-rawatan dengan L-NAME atau MB telah didapati 
meningkatkan (PC0.05) aktiviti itu. Berdasarkan penemuan ini, kepekatan rendah NO, 
yang mana dipengaruhi oleh kehadiran ASH dalam kepekatan tinggi, dan perencatan 
sistem cGMP memainkan peranan penting dalam aktiviti antinosiseptif ASH. 
Walaubagaimanapun, mekanisme sebenar yang mendasari fenomena ini masih belum 
dapat difahami sepenuhnya. 
Sebagai kesimpulannya, kami mencadangkan bahawa aktiviti antinosiseptif yang 
dihasilkan oleh ASH adalah disebabkan oleh kehadiran pelbagai jenis asid-asid amino 
dan asid-asid lemak, serta kehadiran sekurang-kurangnya empat jenis fraksi-fraksi utama, 
dan melibatkan pengaktifan, sekurang-kurangnya, empat jenis reseptor-reseptor bukan 
opioid (iaitu muskarinik, GABA, a-adrenergik dan serotonergik) dan laluan L- 
arginine/NO/cGMP. 
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